The implications of WTO accession on the pharmaceutical industry in China [PDF]
, 2002 Given the limited capabilities of R&D and global distribution channels, and the virtual non-existence of patented drugs, the Chinese pharmaceutical industry has little chance to enter the global market of Western prescription drugs and compete with the ...
Yeung, Godfrey
core +1 more source
The Distributed Partnering Model for Drug Discovery and Development [PDF]
, 2010 Proposes a model for bringing new drugs to market efficiently by creating "product definition companies" that would acquire early-stage discoveries from research institutions and invest in defining product applications to sell to pharmaceutical ...
Duane Roth, Pedro Cuatrecasas
core +1 more source
Multimarket Contact in Pharmaceutical Markets [PDF]
SSRN Electronic Journal, 2007 We analyze the effect of multimarket contact on the pricing behavior of pharmaceutical firms controlling for different levels of regulatory constraints using the IMS MIDAS database for the industry. Theoretically, under product differentiation, firms may find it profitable to allocate their market power among markets where they are operating ...
Javier Coronado +2 more
openaire +8 more sources
A GENERAL OVERVIEW OF THE ROMANIAN PHARMACEUTICAL MARKET [PDF]
Analele Universităţii Constantin Brâncuşi din Târgu Jiu : Seria Economie, 2015 The pharmaceutical sector is one of the state’s largest suppliers of goods and services, one of the biggest taxpayers contributing to the state budget revenue, as well as the state’s largest creditor.
ȘTELIAC NELA
doaj
Research of the dynamics of wholesale segment concentration level in the regional pharmaceutical market [PDF]
PharmaciaIntroduction: The study of the competitive environment in the pharmaceutical market is an element of the analysis of the drug supply system. The purpose of the study is to analyze the dynamics of concentration levels in the wholesale segment of the ...
Andrey Goryachev +7 more
doaj +3 more sources
Institutional Ownership and Concentration of Capital in Pharmaceutical Companies: Evidence from Iran [PDF]
Journal of Evidence Based Health Policy, Management & Economics, 2023 Background: Institutional owners influence the direction of policy and the performance of owned companies. This research was motivated by the presence of pharmaceutical companies in the Tehran Stock Exchange and the uncertainty surrounding the extent and
Rouhollah Yaghoubi +5 more
doaj
Three Seas Economic Journal, 2020 The purpose of the paper is to summarize and present the differences in the competitive environment of the European Union (EU) and Ukrainian pharmaceutical markets.
Iryna Budnikevych, Vadym Honchar
doaj +1 more source
Trend analysis of medicine consumption based on therapeutic categories in Iran: 2000–2016
Journal of Research in Pharmacy Practice, 2018 Objective: Iranian healthcare system cost has been remarkably growing during the recent decades. Drug shortages and the economic effects of the sanctions have also exposed the pitfalls and shortcomings of the pharmaceutical system.
Alireza Yektadoost +5 more
doaj +1 more source
Trends in China’s pharmaceutical market during the COVID-19 epidemic [PDF]
SHS Web of ConferencesThe COVID-19 epidemic has had a significant impact on the Chinese pharmaceutical market, leading to substantial changes in demand, production, supply, and market size.
Nie Shilin
doaj +1 more source
Why licensing authorities need to consider the net value of new drugs in assigning review priorities: Addressing the tension between licensing and reimbursement [PDF]
, 2008 Pharmaceutical regulators and healthcare reimbursement authorities operate in different intellectual paradigms and adopt very different decision rules. As a result, drugs that have been licensed are often not available to all patients who could benefit ...
Angell +6 more
core +1 more source